Molly Henderson is CFO at Phathom Pharmaceuticals, Inc. (PHAT). They have made 14 open-market trades across 3 companies since 2008, most recently 2025-04-07.
CIK 0001363812
3 open-market purchases totalling $51K since 2008, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PHAT | SELL | 2025-04-07 | 2025-04-08 | $4.55 | $17K | -6.3% | -45.0% | +108.2% |
| PHAT | SELL | 2025-01-21 | 2025-01-23 | $6.59 | $43K | -15.4% | -25.3% | -43.8% |
| PHAT | SELL | 2024-12-19 | 2024-12-20 | $8.00 | $10K | +4.3% | -8.5% | -15.6% |
| PHAT | SELL | 2024-07-15 | 2024-07-17 | $11.72 | $51K | -3.7% | +4.6% | +31.6% |
| PHAT | SELL | 2024-04-08 | 2024-04-10 | $11.10 | $38K | -23.7% | -19.3% | -11.0% |
| PHAT | SELL | 2024-01-19 | 2024-01-22 | $7.75 | $49K | -14.9% | +30.4% | +15.1% |
| PHAT | SELL | 2023-11-20 | 2023-11-21 | $7.24 | $15K | +16.4% | +24.0% | +40.5% |
| PHAT | SELL | 2023-11-01 | 2023-11-03 | $8.91 | $215K | -12.1% | +1.0% | -20.2% |
| PHAT | SELL · 10b5-1 | 2023-06-02 | 2023-06-05 | $11.41 | $22K | +7.8% | +16.8% | +16.2% |
| PHAT | SELL · 10b5-1 | 2023-05-22 | 2023-05-23 | $12.87 | $27K | -1.3% | +9.7% | +26.9% |
| PHAT | SELL · 10b5-1 | 2023-04-06 | 2023-04-07 | $7.27 | $25K | +38.5% | +59.4% | +78.2% |
| PHAT | SELL · 10b5-1 | 2023-03-01 | 2023-03-03 | $8.53 | $17K | -21.3% | -16.5% | +30.8% |
| PHAT | SELL | 2022-11-21 | 2022-11-23 | $9.60 | $21K | +12.4% | +15.9% | -2.9% |
| URGN | SELL | 2022-01-31 | 2022-02-02 | $7.58 | $3K | -2.4% | -14.9% | -4.9% |
| URGN | SELL | 2021-11-30 | 2021-12-02 | $12.03 | $31K | -17.0% | -18.6% | -49.2% |
| URGN | BUY | 2021-05-17 | 2021-05-18 | $15.85 | $40K | +0.9% | -3.9% | -14.5% |
| VSCP | BUY | 2012-06-19 | 2012-06-21 | $0.90 | $7K | N/A | N/A | N/A |
| VSCP | BUY | 2008-03-14 | 2008-03-17 | $0.68 | $4K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.